index - CRCL-Analyse intégrée de la dynamique du cancer

Kévin Berthenet, Eliézer Aïmontché, Sara El Mrini, Johan Brière, Nathalie Pion, et al.. Spatial sequestration of activated-caspase 3 in aggresomes mediates resistance of neuroblastoma cell to bortezomib treatment. Scientific Reports, 2024, 14, ⟨10.1038/s41598-024-54140-7⟩. ⟨hal-04482149⟩
Christian Pozzorini, Gregoire Andre, Tommaso Coletta, Adrien Buisson, Jonathan Bieler, et al.. GIInger predicts homologous recombination deficiency and patient response to PARPi treatment from shallow genomic profiles. Cell Reports Medicine, 2023, 4, ⟨10.1016/j.xcrm.2023.101344⟩. ⟨hal-04400735⟩
Amine Bouhamama, Benjamin Leporq, Khuram Faraz, Jean-Philippe Foy, Maxime Boussageon, et al.. Radiomics combined with transcriptomics to predict response to immunotherapy from patients treated with PD-1/PD-L1 inhibitors for advanced NSCLC. Frontiers in Radiology, 2023, 3, ⟨10.3389/fradi.2023.1168448⟩. ⟨hal-04209979⟩
Angèle Coutant, Vincent Cockenpot, Lauriane Muller, Cyril Degletagne, Roxane Pommier, et al.. Spatial transcriptomics reveal pitfalls and opportunities for the detection of rare high-plasticity breast cancer subtypes. Laboratory Investigation, 2023, ⟨10.1101/2023.04.24.538061⟩. ⟨hal-04104604v2⟩
Tan Mai Nguyen, Chloé Bertolus, Paul Giraud, Anita Burgun, Pierre Saintigny, et al.. A Radiomics Approach to Identify Immunologically Active Tumor in Patients with Head and Neck Squamous Cell Carcinomas. Cancers, 2023, 15 (22), pp.5369. ⟨10.3390/cancers15225369⟩. ⟨hal-04459206⟩
Boris Guyot, Flora Clément, Youenn Drouet, Xenia Schmidt, Sylvain Lefort, et al.. An Early Neoplasia Index (ENI10), Based on Molecular Identity of CD10 Cells and Associated Stemness Biomarkers, is a Predictor of Patient Outcome in Many Cancers. Cancer Research Communications, 2023, 3 (9), pp.1966-1980. ⟨10.1158/2767-9764.CRC-23-0196⟩. ⟨hal-04237719⟩

Derniers manuscrits de l'équipe

Chiffres clés